Literature DB >> 31216057

Endocytic recycling of Na+ -K+ -Cl- cotransporter type 2: importance of exon 4.

Andrée-Anne Marcoux1, Samira Slimani1, Laurence E Tremblay1, Rachelle Frenette-Cotton1, Alexandre P Garneau1,2, Paul Isenring1.   

Abstract

KEY POINTS: Na+ -K+ -Cl- cotransporter type 2 (NKCC2) is a 27-exon membrane protein that is expressed in the thick ascending limb (TAL) of Henle where it is involved in reabsorption of the ultrafiltered NaCl load. It comes as three splice variants that are identical to each other except for the residue composition of exon 4 and that differ in their transport characteristics, functional roles and distributions along the TAL. In this report, it is shown that the variants also differ in their trafficking properties and that two residues in exon 4 play a key role in this regard. One of these residues was also shown to sustain carrier internalization. Through these results, a novel function for the alternatively spliced exon of NKCC2 has been identified and a domain that is involved in carrier trafficking has been uncovered for the first time in a cation-Cl- cotransporter family member. ABSTRACT: Na+ -K+ -Cl- cotransporter type 2 (NKCC2) is a 12-transmembrane (TM) domain cell surface glycoprotein that is expressed in the thick ascending limb (TAL) of Henle and stimulated during cell shrinkage. It comes as three splice variants (A, B and F) that are identical to each other except for TM2 and the following connecting segment (CS2). Yet, these variants do not share the same localization, transport characteristics and physiological roles along the TAL. We have recently found that while cell shrinkage could exert its activating effect by increasing NKCC2 expression at the cell surface, the variants also responded differentially to this stimulus. In the current work, a mutagenic approach was exploited to determine whether CS2 could play a role in carrier trafficking and identify the residues potentially involved. We found that when the residue of position 238 in NKCC2A (F) and NKCC2B (Y) was replaced by the corresponding residue in NKCC2F (V), carrier activity increased by over 3-fold and endocytosis decreased concomitantly. We also found that when the residue of position 230 in NKCC2F (M) was replaced by the one in NKCC2B (T), carrier activity and affinity for ions both increased substantially whereas expression at the membrane decreased. Taken together, these results suggest that CS2 is involved in carrier trafficking and that two of its residues, those of positions 238 and 230, are part of an internalization motif. They also indicate that the divergent residue of position 230 plays the dual role of specifying ion affinity and sustaining carrier internalization.
© 2019 The Authors. The Journal of Physiology © 2019 The Physiological Society.

Entities:  

Keywords:  CCC; NKCC2; Na+-K+-Cl− cotransporter type 2; cation-Cl− cotransporters; cell surface expression; protein trafficking; structure-function studies

Year:  2019        PMID: 31216057     DOI: 10.1113/JP278024

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  3 in total

1.  New molecular motif contributes to NKCC2 trafficking.

Authors:  Keyona N King-Medina; Cesar A Romero
Journal:  J Physiol       Date:  2019-10-31       Impact factor: 5.182

2.  The structure of Na+-K+-Cl- cotransporter 1.

Authors:  Alexandre P Garneau; Paul Isenring
Journal:  Nat Rev Nephrol       Date:  2019-12       Impact factor: 28.314

3.  Phospho-regulation, nucleotide binding and ion access control in potassium-chloride cotransporters.

Authors:  Gamma Chi; Rebecca Ebenhoch; Henry Man; Haiping Tang; Laurence E Tremblay; Gabriella Reggiano; Xingyu Qiu; Tina Bohstedt; Idlir Liko; Fernando G Almeida; Alexandre P Garneau; Dong Wang; Gavin McKinley; Christophe P Moreau; Kiran D Bountra; Patrizia Abrusci; Shubhashish M M Mukhopadhyay; Alejandra Fernandez-Cid; Samira Slimani; Julie L Lavoie; Nicola A Burgess-Brown; Ben Tehan; Frank DiMaio; Ali Jazayeri; Paul Isenring; Carol V Robinson; Katharina L Dürr
Journal:  EMBO J       Date:  2021-05-25       Impact factor: 14.012

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.